Available to sourceHuman Prescription DrugOncology & Specialty

Gomekli (mirdametinib)

1 mg/1 · Capsule

By SpringWorks Therapeutics, Inc.

NDC: 82448-130
Route: Oral
Therapeutic class: Kinase Inhibitor , Mitogen-Activated Protein Kinase Kinase 1 Inhibitors [MoA], Mitogen-Activated Protein Kinase Kinase 2 Inhibitors [MoA]
Marketing category: NDA

Package sizes

42 CAPSULE in 1 BOTTLE (82448-130-42)NDC 82448-130-42Available to order

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request this medication

Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

Related in Oncology & Specialty

See all →

Gomekli (mirdametinib)

Package sizes

Additional information

Request this medication

Related in Oncology & Specialty

Verzenio (abemaciclib)

Verzenio (abemaciclib)

Verzenio (abemaciclib)

Verzenio (abemaciclib)